← Insider buys
RMD

ResMed Inc. · Healthcare

Chief Administrative Officer David Pendarvis sold $356K of ResMed Inc.

Sold$356,460
$237.64Price
1,500Shares
−2%Stake

What RMD did after the filing

Filed May 4, copier in the same day
The stock from Thu, May 4 close, $232.09
−5.6%
S&P 500, same days
+8.9%

Measured over 30 trading days, to the Jun 16 close.

Traded Wed, May 3. Filed Thu, May 4, 3:49 PM ET, during the session. Returns use the May 4 close and the Jun 16 close. Not investment advice.